Evidence map›Paper›PMID 39267052›Full record

ArticleBMC medicine2024

Association of depressive symptoms with incidence and mortality rates of COVID-19 over 2 years among healthcare workers in 20 countries: multi-country serial cross-sectional study.

Hiroki Asaoka, Kazuhiro Watanabe, Yuki Miyamoto, Alexandra Restrepo-Henao, Els van der Ven, Maria Francesca Moro, Lubna A Alnasser, Olatunde Ayinde, Arin A Balalian, Armando Basagoitia and 33 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in BMC medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04352634 (The Impact of the Covid-19 Pandemic on the Mental Health of Workers in Health Services), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04352634 unknown statusnot on this map

The Impact of the Covid-19 Pandemic on the Mental Health of Workers in Health Services: The Covid-19 HEalth caRe wOrkErS (HEROES) Study

TypeobservationalSponsorUniversity of ChileRan2020 to 2021Enrolled2,000ConditionsCovid-19, Mental Health Disorder, Stress Disorder, AnxietyArmsExposure to the SARS-CoV-2 and its consequences
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

Hiroki AsaokaDepartment of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyoku, Tokyo, 113-0033, Japan.
Kazuhiro WatanabeDepartment of Public Health, Kitasato University School of Medicine, Sagamihara, Japan.
Yuki MiyamotoDepartment of Psychiatric Nursing, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Alexandra Restrepo-HenaoNational School of Public Health Universidad de Antioquia, Medellín, Colombia.
Els van der VenDepartment of Clinical, Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Maria Francesca MoroDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, USA.
Lubna A AlnasserDepartment of Population Health, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard, Riyadh, Saudi Arabia.
Olatunde AyindeDepartment of Psychiatry, University of Ibadan, Ibadan, Nigeria.
Arin A BalalianQuestion Driven Design and Analysis Group (QD-DAG), New York, USA.
Armando BasagoitiaSalud Global Bolivia, La Paz, Bolivia.
Sol Durand-AriasInstituto Nacional de Psiquiatría Ramón de La Fuente Muñiz, Mexico City, Mexico.
Mehmet EskinDepartment of Psychology, Koc University, Istanbul, Turkey.
Eduardo Fernández-JiménezDepartment of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain.
Freytes Frey Marcela InesUniversidad del Chubut, Escuela de Salud Social y Comunitaria, Chubut, Argentina.
Luis GiménezHealth Psychology Institute, Faculty of Psychology, University of the Republic, Montevideo, Uruguay.
Hans W HoekDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, USA.
Rodrigo Ezequiel JaldoEscuela de Salud Social y Comunitaria, Universidad del Chubut, Chubut, Argentina.
Jutta LindertFaculty of Health and Social Work, University of Applied Sciences Emden / Leer, Emden, Germany.
Humberto MaldonadoDirección de Salud Mental, Ministerio de Salud, Lima, Peru.
Gonzalo Martínez-AlésHarvard T.H. Chan School of Public Health, Harvard University, Cambridge, USA.
Roberto MediavillaDepartment of Psychiatry, Universidad Autónoma de Madrid, Madrid, Spain.
Clare McCormackDepartment of Child and Adolescent Psychiatry, NYU Langone Health, New York, USA.
Javier NarvaezDepartment of Public Health, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
Uta OualiDepartment Psychiatry A, Razi Hospital La Manouba, Manouba, Tunisia.
Aida Barrera-PerezSchool of Medicine, University of San Carlos of Guatemala, Guatemala City, Guatemala.
Erwin Calgua-GuerraSchool of Medicine, University of San Carlos of Guatemala, Guatemala City, Guatemala.
Jorge RamírezEscuela de Salud Pública CL, Faculty of Medicine, University of Chile, Santiago, Chile.
Ana María RodríguezInstituto Altos Estudios Dr Arnoldo Gabaldon, Maracay, Venezuela.
Dominika SeblovaDepartment of Epidemiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Andrea Tenorio Correia da SilvaFaculty of Medicine, University of São Paulo, São Paulo, Brazil.
Linda ValeriDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.
Oye GurejeDepartment of Psychiatry, University of Ibadan, Ibadan, Nigeria.
Dinarte BallesterFaculty of Medicine, Federal University of Pelotas, Pelotas, Brazil.
Mauro Giovanni CartaUniversità Degli Studi Di Cagliari, Cagliari, Italy.
Anna IsahakyanNational Institute of Health Named After Academician S. Avdalbekyan, Yerevan, Armenia.
Amira JamoussiFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Jana SeblovaDepartment of Epidemiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Maria Teresa Solis-SotoResearch, Science and Technology Direction, Universidad San Francisco Xavier de Chuquisaca, Sucre, Bolivia.
Ruben AlvaradoInterdisciplinary Centre for Health Studies (CIESAL), Department of Public Health, School of Medicine, Faculty of Medicine, Universidad de Valparaíso, Valparaíso, Chile.
Ezra SusserColumbia University Mailman School of Public Health, New York, NY, USA.
Franco MascayanoDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, USA.
Daisuke NishiDepartment of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyoku, Tokyo, 113-0033, Japan. d-nishi@m.u-tokyo.ac.jp.
HEROES group

Funding

Training the Next Generation of Psychiatrists-Scientists for Translational ResearchR25MH129256 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ANTONIA S NEW, Maria De Las Mercedes Perez Rodriguez · 2023 to 2026
$831k
NIMH NIH HHS R25 MH129256
6 · The paper itself

Abstract

backgroundLong-term deterioration in the mental health of healthcare workers (HCWs) has been reported during and after the COVID-19 pandemic. Determining the impact of COVID-19 incidence and mortality rates on the mental health of HCWs is essential to prepare for potential new pandemics. This study aimed to investigate the association of COVID-19 incidence and mortality rates with depressive symptoms over 2 years among HCWs in 20 countries during and after the COVID-19 pandemic.

methodsThis was a multi-country serial cross-sectional study using data from the first and second survey waves of the COVID-19 HEalth caRe wOrkErS (HEROES) global study. The HEROES study prospectively collected data from HCWs at various health facilities. The target population included HCWs with both clinical and non-clinical roles. In most countries, healthcare centers were recruited based on convenience sampling. As an independent variable, daily COVID-19 incidence and mortality rates were calculated using confirmed cases and deaths reported by Johns Hopkins University. These rates represent the average for the 7 days preceding the participants' response date. The primary outcome was depressive symptoms, assessed by the Patient Health Questionnaire-9. A multilevel linear mixed model (LMM) was conducted to investigate the association of depressive symptoms with the average incidence and mortality rates.

resultsA total of 32,223 responses from the participants who responded to all measures used in this study on either the first or second survey, and on both the first and second surveys in 20 countries were included in the analysis. The mean age was 40.1 (SD = 11.1), and 23,619 responses (73.3%) were from females. The 9323 responses (28.9%) were nurses and 9119 (28.3%) were physicians. LMM showed that the incidence rate was significantly and positively associated with depressive symptoms (coefficient = 0.008, standard error 0.003, p = 0.003). The mortality rate was significantly and positively associated with depressive symptoms (coefficient = 0.049, se = 0.020, p = 0.017).

conclusionsThis is the first study to show an association between COVID-19 incidence and mortality rates with depressive symptoms among HCWs during the first 2 years of the outbreak in multiple countries. This study's findings indicate that additional mental health support for HCWs was needed when the COVID-19 incidence and mortality rates increase during and after the early phase of the pandemic, and these findings may apply to future pandemics.

trial registrationClinicaltrials.gov, NCT04352634.

Indexed as

COVID-19DepressionHealth PersonnelAdultCross-Sectional StudiesFemaleHumansIncidenceMaleMiddle AgedSARS-CoV-2COVID-19Depressive symptomsHealthcare workerIncidence rateMortality rateMulti-country studySerial cross-sectional study

Identifiers

PMID39267052
PMCPMC11395223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.